Top Markets
Coin of the day
Perseus Proteomics Inc. Perseus Proteomics Inc.

Perseus Proteomics Inc.

4882
Classement en actions #30379
Based in Tokyo, Japan, Perseus Proteomics Inc. operates as a biotechnology... Based in Tokyo, Japan, Perseus Proteomics Inc. operates as a biotechnology venture specializing in the development of antibody-based therapeutics for various ailments, including cancer. Its core operations encompass pioneering antibody discovery, alongside providing extensive research support services. These services include hybridoma antibody sequencing, the production of antibody proteins, and undertaking contract antibody research projects. Furthermore, Perseus Proteomics supplies its own antibody products to the market. The company boasts a robust development pipeline featuring several promising candidates: PPMX-T001, an antibody targeting hepatocarcinoma; PPMX-T002, an oncology therapeutic; PPMX-T003, designed for the treatment of adult T-cell leukemia/lymphoma; and PPMX-T004, an innovative antibody-drug conjugate. Established in 2001, the firm maintains its headquarters in the Japanese capital.
Prix de l'action
$0.91993619
Capitalisation boursière
$16.95M
Changement (1 jour)
-2.76%
Changement (1 an)
-63.00%
Pays
JP
Échange Perseus Proteomics Inc. (4882)

Catégorie

Historique des divisions d’actions pour Perseus Proteomics Inc. (4882)
L’action Perseus Proteomics Inc. (symbole : 4882) a subi un total de 0 divisions.
La division la plus récente a eu lieu le Aug 19, 2026.
Une action 4882 achetée avant le Aug 19, 2026 équivaudrait aujourd’hui à 0 actions 4882.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
Pas assez de données pour les dates fournies.
Divisions d’actions d’entreprises similaires ou concurrentes
Entreprise Nombre de divisions d’actions Multiplicateur cumulatif Pays
4 x15
US
7 x432
US
0 -
US
2 x10000
CH
7 x226
US